Yanovsky Alona on Muck Rack

Yanovsky Alona

As seen in: International Journal of Cardiology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Yanovsky

Contact Yanovsky, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) inhibitors and the risk for neurocognitive adverse events: A systematic review, meta-analysis and meta-regression

|
By Bruria Hirsh Raccah, Yanovsky Alona, Nir Treves, Victoria Rotshild
| International Journal of Cardiology Verified
Highlights • Lipid lowering therapy may be associated with impaired cognitive function. • This meta-analysis included 21 studies with a total of 59,733 patients. • PCSK9 inhibitors are not associated with increased risk of neurocognitive adverse events. • A longer exposure was associated with decreased RR for neurocognitive adverse events. Abstract Background It has been suggested that lipid lowering therapy causes impaired cognitive changes.
Open in Who Shared Issue with article?
See all 1 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified